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Fine-tuning of insulin secretion from pancreatic b-cells
participates in blood glucose homeostasis. Defects in
this process can lead to chronic hyperglycemia and dia-
betes mellitus. Several proteins controlling insulin exo-
cytosis have been identified, but the mechanisms
regulating their expression remain poorly understood.
Here, we show that two non-coding microRNAs,
miR124a and miR96, modulate the expression of pro-
teins involved in insulin exocytosis and affect secretion
of the b-cell line MIN6B1. miR124a increases the levels
of SNAP25, Rab3A and synapsin-1A and decreases
those of Rab27A and Noc2. Inhibition of Rab27A expres-
sion is mediated by direct binding to the 39-untranslated
region of Rab27A mRNA. The effect on the other genes
is indirect and linked to changes in mRNA levels. Over-
expression of miR124a leads to exaggerated hormone
release under basal conditions and a reduction in glu-
cose-induced secretion. miR96 increases mRNA and
protein levels of granuphilin, a negative modulator of
insulin exocytosis, and decreases the expression of
Noc2, resulting in lower capacity of MIN6B1 cells to
respond to secretagogues. Our data identify miR124a
and miR96 as novel regulators of the expression of pro-
teins playing a critical role in insulin exocytosis and in the
release of other hormones and neurotransmitters.
Keywords: exocytosis; insulin secretion; microRNA;
neurotransmitter release; pancreatic b-cell.
Introduction
Insulin secretion from pancreatic b-cells is an essential
requirement for blood glucose homeostasis. The release
of inappropriate amounts of this hormone leads to severe
changes in blood glucose levels that favor the develop-
ment of diabetes mellitus. The insulin secretory pathway
is complex and involves a number of steps that allow
vesicular transport of the hormone from rough endoplas-
mic reticulum to the Golgi apparatus and its delivery to
the cell periphery. Although all these events occur in a
highly coordinated fashion, the minute-to-minute control
of insulin release is mainly accomplished through fine-
tuning of exocytosis, the final step of the secretory
pathway. During the last decade several, essential com-
ponents of the molecular machinery that drives insulin
exocytosis have been identified. Interestingly, b-cell exo-
cytosis was found to rely on a group of proteins playing
a key role in neurotransmitter release, including the
SNAREs syntaxin-1, SNAP25 and VAMP2, the SNARE-
interacting proteins Munc18-1, Munc13-1, complexin I
and the Ras-like GTPase Rab3A (Lang, 1999; Gerber and
Sudhof, 2002; Rorsman and Renstrom, 2003). Indeed,
despite endodermal origin, pancreatic b-cells display a
gene expression pattern largely overlapping that of neu-
ronal cells, probably reflecting physiological similarities in
secretory functions and electrical coupling. However,
insulin secretion also requires the contribution of non-
neuronal proteins such as granuphilin, Noc2 and Rab27A
that are selectively enriched in endocrine cells (Matsu-
moto et al., 2004; Gomi et al., 2005; Kasai et al., 2005).
Appropriate balance between neuron-specific and endo-
crine-specific components appears to be required for
optimal secretory functions of b-cells. Indeed, ectopic
expression of REST/NRSF (response element silencing
transcription factor), a neuronal repressor whose
absence in mature b-cells and neurons allows the
expression of neuronal phenotypic traits, leads to impair-
ment of glucose-induced insulin secretion (Abderrahmani
et al., 2004).
Chronic exposure to elevated levels of glucose and
saturated free fatty acids has a deleterious impact on
b-cell secretory functions and is thought to promote the
development of diabetes (Prentki and Nolan, 2006).
Accumulating evidence indicates that defective insulin
release may not only be linked to altered expression of
metabolic enzymes and glucose signaling, but could also
result from differences in the level of critical components
of the secretory machinery of b-cells. Indeed, the expres-
sion of genes required for insulin exocytosis has been
found to be altered in both diabetes animal models
(Nagamatsu et al., 1999; Gaisano et al., 2002) and pan-
creatic islets of diabetic patients (Ostenson et al., 2006).
Unfortunately, the molecular mechanisms governing the
expression of the key genes involved in insulin exocy-
tosis are poorly understood. We recently demonstrated
that induction of the transcriptional repressor ICER in
response to prolonged exposure to supraphysiological
glucose concentrations led to a strong reduction in the
expression of the GTPases Rab3A, Rab27A and in two
of their effectors, granuphilin and Noc2 (Abderrahmani et
al., 2006). However, changes in the level and/or activity
of other molecules regulating gene expression are very
likely to contribute to b-cell secretory dysfunction.
Gene expression and cell differentiation are controlled
by the concerted action of a large number of transcription
factors. However, eukaryotic cells were recently discov-
ered to express hundreds of small (approx. 22 nt) non-
coding RNAs called microRNAs (miRNAs) that play
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Figure 1 Effect of different miRNAs on basal and stimulated
secretion.
MIN6B1 cells were transiently co-transfected with an hGH-
encoding plasmid and with oligonucleotide duplexes containing
the mature sequence of the miRNAs indicated. Control cells
were co-transfected with an unrelated oligonucleotide duplex
(see materials and methods). Three days later the cells were
incubated either with 2 mM glucose (basal, upper panel) or
20 mM glucose, 10 mM forskolin and 100 mM IBMX (stimulated,
lower panel). The fractions of hGH released in the medium or
remaining in the cells at the end of the incubation period were
determined by ELISA. The results are given as a percentage of
the values obtained for control cells and correspond to the
mean"SEM of four or five independent experiments performed
in triplicate for each miRNA. Over the 45-min incubation period,
control cells secreted 6.5% of their hGH content under basal
conditions and 68% in the presence of the stimuli. *Significantly
different from control cells (p-0.05 by ANOVA).
previously unsuspected roles in the regulation of gene
expression (Bartel, 2004; Alvarez-Garcia and Miska,
2005). The members of this new class of gene regulators
function by partially pairing to sequences in the 39-
untranslated region (39UTR) of target mRNAs and by
inhibiting their translation. The immense regulatory
potential of miRNAs is only beginning to be appreciated,
but the involvement of these tiny RNA molecules in a
variety of physiological processes and in human diseases
has already been established. Moreover, there is also evi-
dence of the involvement of miRNAs in the control of
pancreatic b-cell functions. Indeed, miR9 and miR375
were found to influence directly or indirectly the expres-
sion of proteins involved in exocytosis and to affect insu-
lin secretion (Poy et al., 2004; Plaisance et al., 2006).
Better knowledge of the molecular mechanisms con-
trolling expression of the genes required for insulin exo-
cytosis is needed both to improve our understanding of
the differentiation process leading to the acquisition of a
secretory phenotype of b-cells and to elucidate the fac-
tors affecting insulin secretion in pathophysiological con-
ditions. In this study, we identified two miRNAs governing
the expression of key components of the machinery of
exocytosis of b-cells and demonstrate that changes in
their cellular levels are associated with secretory
dysfunctions.
Results
Two miRNAs, miR9 and miR375, have been previously
demonstrated to control directly or indirectly the secre-
tory functions of pancreatic b-cells (Poy et al., 2004; Plai-
sance et al., 2006). To identify other miRNAs potentially
involved in the regulation of insulin secretion, we trans-
fected the mouse b-cell line MIN6B1 (Lilla et al., 2003)
with RNA duplexes containing the sequences of the
mature form of different miRNAs. We selected miRNAs
enriched in neurons and/or b-cells (miR7, miR9, miR124a
and miR375), as well as miRNAs with a much broader
expression pattern (miR15b, miR96, miR146, miR153,
miR195, miR210). Some miRNAs have been found to
affect insulin biosynthesis (Baroukh et al., 2007). To avoid
potentially confounding effects of miRNAs on insulin bio-
synthesis, the cells were co-transfected with a plasmid
leading to constitutive expression of human growth hor-
mone (hGH). When introduced into b-cells, hGH is pack-
aged in dense-core granules and is co-released with
insulin, allowing the monitoring of exocytosis from tran-
siently transfected insulin-secreting cells independently
from their capacity to produce insulin (Varadi et al., 2002).
In addition, since hGH is exclusively secreted from cells
overexpressing the miRNAs, this strategy maximizes the
possibilities to detect potential secretory defects in the
case of suboptimal transfection efficiency. Three days
after transfection, hormone secretion was measured
under basal conditions (2 mM glucose) and in the pres-
ence of 20 mM glucose and cAMP-raising agents, a con-
dition that triggers a strong secretory response in these
cells (Lilla et al., 2003). We found that overexpression of
miR124a and miR96 causes distinct changes in the cel-
lular secretory properties. Indeed, miR124a led to a sig-
nificant increase in hormone release at low glucose
concentration and to a reduction in the cellular capacity
to respond to secretagogues (Figure 1). An increase in
miR96 was also associated with a diminished cellular
response to glucose and cAMP-raising agents, but this
miRNA did not affect basal secretion. As previously
reported, overexpression of miR9 (Plaisance et al., 2006)
and miR375 (Poy et al., 2004) did not alter basal hormone
release, but reduced exocytosis from cells stimulated by
secretagogues to an extent comparable to that of miR96
(Figure 1). In contrast, the other miRNAs, including miR7
and miR15b (Figure 1), did not modify the secretory prop-
erties of MIN6B1 cells.
In view of these findings we used Western blotting to
analyze the expression of a series of proteins known to
play a central role in insulin exocytosis (Lang, 1999; Ger-
ber and Sudhof, 2002; Rorsman and Renstrom, 2003).
We found that miR124a increases the expression of
SNAP25, Rab3A and synapsin-1A, whereas the levels of
Rab27A and Noc2 were reduced (Figure 2). The expres-
sion of other key components of the machinery of exo-
cytosis of b-cells and of the cytoskeletal proteins tubulin
and actin was unaffected. miR96-transfected cells were
found to express higher levels of granuphilin, a Rab
effector known to negatively modulate insulin exocytosis
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Figure 2 Expression of key components of the exocytotic
machinery in cells overexpressing miR124a or miR96.
MIN6B1 cells were transiently transfected with oligonucleotide
duplexes corresponding to the mature sequence of miR124a or
miR96 or with a control RNA duplex. Three days later the cells
were homogenized and the expression of the indicated com-
ponents of the insulin secretory machinery was analyzed by
Western blotting. The Figure shows representative images of at
least three independent experiments.
Figure 3 Expression of key components of the exocytotic
machinery in cells overexpressing miR9 or miR375.
MIN6B1 cells transfected with oligonucleotide duplexes corre-
sponding to the mature sequence of miR9, miR375 or with a
control RNA duplex were homogenized and the expression of
the indicated components of the insulin secretory machinery
was analyzed by Western blotting. The Figure shows represen-
tative images of at least three independent experiments.
Figure 4 mRNA levels of different components of the exo-
cytotic machinery in cells overexpressing miR124a and miR96.
MIN6B1 cells were transfected with a control RNA duplex or with
an RNA duplex containing the mature sequence of miR124a or
miR96. Three days later, total RNA was extracted and the mRNA
levels of the indicated components of the exocytotic machinery
were determined by RT-PCR analysis. The level of each mRNA
in cells overexpressing miR124a and miR96 is given as a
percentage of the mRNA content in control cells. The values
significantly different from controls (p-0.05) are indicated by
asterisks.
(Coppola et al., 2002; Gomi et al., 2005), and lower
amounts of Noc2, an essential component of the b-cell
secretory machinery (Cheviet et al., 2004; Matsumoto et
al., 2004). Levels of all the other components of the
b-cell secretory machinery tested were unchanged (Fig-
ure 2). The effect of miR124a on the exocytotic proteins
was clearly distinct from those of miR9 and miR375 (Fig-
ure 3). In contrast, the effect of miR96 was partially sim-
ilar to that of miR9 (Figure 3).
The mechanisms underlying the effect of the two
miRNAs on the proteins of the exocytotic machinery was
then investigated in more detail. miRNAs are generally
believed to function as translational repressors (Bartel,
2004; Alvarez-Garcia and Miska, 2005), and SNAP25,
Rab3A and synapsin-1A are not among the predicted tar-
gets of miR124a (John et al., 2004; Krek et al., 2005;
Lewis et al., 2005). Moreover, the increase in SNAP25,
synapsin-1A and Rab3A proteins correlates with an
increase in the corresponding mRNAs (Figure 4). Taken
together, these observations suggest that miR124a
action is indirect and probably mediated by changes in
gene transcription. In contrast to the other components,
the inhibition of Rab27A and Noc2 expression would in
principle be compatible with a direct effect of miR124a
on mRNA translation. Indeed, putative miR124a recog-
nition sites have been identified in the 39UTR of Rab27A
and Noc2 mRNAs (John et al., 2004; Krek et al., 2005;
Lewis et al., 2005). To verify these computational predic-
tions, the sequences corresponding to the putative
miR124a recognition sites in Rab27A and Noc2 mRNAs
were cloned in the 39UTR of a luciferase reporter plasmid.
Co-transfection in MIN6B1 cells revealed that overex-
pression of miR124a decreases the amount of luciferase
produced from the construct bearing the recognition
sequence located in the Rab27A mRNA (Figure 5A). The
effect was even more pronounced with a luciferase con-
struct including a larger portion of the Rab27A 39UTR that
encompasses two putative miR124a binding sites (Figure
5A). Overexpression of another miRNA (miR15b) had no
effect on both of these constructs (data not shown).
miR124a was unable to modulate the expression of a
luciferase plasmid containing the 39UTR of an unrelated
gene (OC2) (Figure 5A). These observations indicate that
miR124a exerts its action on Rab27A by directly binding
to the GTPase mRNA and by inhibiting its translation.
In agreement with this assumption, despite a strong
decrease in Rab27A protein levels, there was no signifi-
cant effect of miR124a on Rab27A mRNA content (Figure
4). In contrast to the results obtained with Rab27A con-
structs, the luciferase activity generated by the plasmid
containing the putative target sequence identified in the
39UTR of Noc2 mRNA was not affected by the overex-
pression of miR124a (Figure 5B). Moreover, the decrease
in Noc2 protein elicited by miR124a was accompanied
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Figure 5 Rab27a is a direct target of miR124a, but not Noc2.
(A) MIN6B1 cells were transfected with a luciferase reporter con-
struct containing one of the miR124a recognition sites present
in Rab27A mRNA (RS 39UTR Rab27A), a larger portion of the
39UTR of Rab27A containing putative recognition sites (39UTR
Rab27A) or the entire 39UTR of OC2 (39UTR OC2). Each of the
reporter constructs was co-transfected either with a control RNA
duplex (open bars) or with an RNA duplex corresponding to the
mature sequence of miR124a (gray bars). The luciferase activity
produced from the different reporter constructs was measured
2 days later. The results show one representative experiment out
of three. (B) Cells were transiently transfected with a luciferase
reporter construct containing the putative miR124a recognition
sequence located in the 39UTR of Noc2 (RS 39UTR Noc2),
together with either a control RNA duplex or with oligonucleotide
duplexes corresponding to the mature sequences of miR124a
and miR15b.
Figure 6 miR96 and miR9 control the expression of granuphilin
via different mechanisms.
(A) MIN6B1 cells were transfected with a control RNA duplex or
with duplexes corresponding to the sequences of miR9 or
miR96. Three days later total RNA was extracted and the level
of granuphilin mRNA was determined by RT-PCR. The granu-
philin mRNA level in control cells was set to 100%. Results are
the mean"SEM for one representative experiment out of three.
(B) Cells were transfected with a luciferase reporter construct
containing the 39UTR of OC2, together with control RNA, miR9
or miR96. The luciferase activity produced from the reporter
construct was measured 3 days later. (C) MIN6B1 cells were
transfected with a control RNA duplex or with duplexes corre-
sponding to the sequences of miR9 or miR96. Three days later
total RNA was extracted and the level of OC2 mRNA levels was
estimated by RT-PCR. Results are expressed as a percentage
of GAPDH mRNA, which was used as an internal control.
by a sizable decrease in the mRNA level (Figure 4). From
these observations we conclude that Noc2 is unlikely to
be a direct target of this miRNA and that the decrease in
expression of this Rab effector is most probably medi-
ated by a change in the level of a transcription factor.
As pointed out above, the impact of miR96 overex-
pression on insulin exocytosis and granuphilin expres-
sion is similar to that of miR9 (Figures 1 and 3) (Plaisance
et al., 2006). For both miR9 and miR96, the increase in
protein amount was correlated with augmentation of
granuphilin mRNA, suggesting an enhancement in gene
transcription (Figure 6A). In the case of miR9, we previ-
ously demonstrated that the increase in granuphilin
expression is caused by translational repression of the
synthesis of One Cut 2 (OC2), a negative regulator of
granuphilin transcription (Plaisance et al., 2006).
Although OC2 is not a predicted target of miR96, we
investigated whether a mechanism similar to that of miR9
was also involved in this case. To this end, we transiently
co-transfected miR96 with a luciferase reporter construct
containing the 39UTR of OC2. As shown in Figure 6B, the
luciferase activity produced from this construct in cells
overexpressing cells miR96 was not significantly different
from that in control cells. In contrast, in agreement with
our previously published data, overexpression of miR9
strongly reduced the expression of the luciferase con-
struct. We then used qRT-PCR to test whether miR96
transfection can affect OC2 mRNA levels via an indirect
mechanism. We found that the amount of OC2 mRNA
present in cells overexpressing miR96 was not signifi-
cantly different from that in control cells, while miR9
reduced OC2 mRNA levels by approximately 50% (Figure
6C). Taken together, these findings indicate that miR9
and miR96 increase the expression of granuphilin via
distinct pathways. As shown in Figure 2, miR96 also
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decreased the amount of Noc2 present in MIN6B1 cells.
The 39UTR of Noc2 mRNA does not contain any potential
recognition sequence for miR96 (John et al., 2004; Krek
et al., 2005; Lewis et al., 2005). We therefore concluded
that the effect of miR96 on the expression of this Rab
effector is most probably indirect.
Discussion
Pancreatic b-cells release insulin in response to fluctua-
tions in circulating levels of glucose and other nutrients.
The insulin secretory process is finely tuned to ensure
the output of an appropriate amount of hormone to meet
metabolic demands. Insufficient insulin supply resulting
from a decrease in b-cell mass and/or defects in their
secretory process leads to chronic hyperglycemia and
diabetes mellitus. During the last decade, a number of
proteins playing an essential role in insulin secretion have
been identified. The expression of several of these pro-
teins in b-cells was found to be altered in diabetes animal
models (Nagamatsu et al., 1999; Gaisano et al., 2002)
and in diabetic patients (Ostenson et al., 2006). More-
over, different studies have reported changes in the level
of some of these components under physiopathological
conditions known to favor the development of type 2 dia-
betes such as chronic hyperglycemia and hyperlipidemia
(Busch et al., 2002; Abderrahmani et al., 2006; Kato et
al., 2006). Unfortunately, mechanisms controlling the
expression of most of the components of the secretory
machinery of b-cells are still poorly understood. Detailed
knowledge of these mechanisms is essential both to elu-
cidate the causes of defective secretion under disease
states and to engineer insulin-secreting cells capable of
replacing lost b-cells in diabetic patients (Halban, 2004).
miRNAs, a newly discovered class of gene regulators,
were recently shown to be essential for pancreatic b-cell
development (Lynn et al., 2007). In this study, we
assessed the role of miRNAs in the expression of pro-
teins required for insulin exocytosis. We found that two
members of this family of small non-coding RNAs,
miR124a and miR96, can affect the expression of several
components of the exocytotic machinery and alter hor-
mone release in insulin-secreting cells. It has been shown
that miR124a is enriched in neuronal tissues and that its
delivery in HeLa cells shifts the gene expression profile
towards that of neurons (Lim et al., 2005). Insulin exo-
cytosis relies to a large extent on proteins abundantly
expressed in neurons that are required for neurotrans-
mitter release (Lang, 1999; Rorsman and Renstrom,
2003). We found that overexpression of miR124a in
MIN6B1 cells increased the level of three such neuronal
genes, SNAP25, Rab3A and synapsin-1A. This would in
principle improve the cellular secretory properties. How-
ever, the miRNA also decreases the level of two central
factors in endocrine secretion, Rab27A and Noc2, finally
leading to impairment of insulin exocytosis. It was recent-
ly shown that miR124a increases during pancreas
embryonic development in a time window that is critical
for b-cell differentiation (Baroukh et al., 2007). Our data
suggest that an increase in miR124a may be needed to
drive the expression of neuronal genes required for insu-
lin exocytosis during b-cell differentiation. In view of our
observations, the level of miR124a needs to be precisely
controlled to avoid detrimental effects on other non-
neuronal components of the secretory apparatus.
The mechanisms by which miRNA affects the expres-
sion of genes of the exocytotic machinery were partially
elucidated in this study. In agreement with previous com-
putational predictions (John et al., 2004; Krek et al.,
2005; Lewis et al., 2005), we have experimentally dem-
onstrated that Rab27A is a direct target of miR124a.
Rab27A is a Ras-like GTPase that controls intracellular
transport and delivery of secretory vesicles to the plasma
membrane in endocrine cells, melanocytes and different
cells of hematopoietic origin (Fukuda, 2005). Interesting-
ly, Rab27A is undetectable in neurons (Tolmachova et al.,
2004). Our data suggest that expression of the GTPase
in neurons is probably prevented by the presence of very
high levels of miR124a. In this study, we obtained evi-
dence that the effect of miR124a on SNAP25, synapsin-
1A, Rab3A and Noc2 is indirect, but we could not define
the precise cascade of events leading to the changes in
expression of these genes. Comparative sequence anal-
yses suggest that miR124a is part of a network including
the transcription factors REST/NRSF and CREB (cAMP
response element-binding protein) that coordinates the
expression of neuronal genes (Wu and Xie, 2006). Since
the genes encoding SNAP25 and synapsin-1A are REST
targets (Bruce et al., 2004), increases in the level of these
proteins may possibly result from further downregulation
of the already low REST activity of b-cells. Another pos-
sible mechanism affecting expression of the exocytotic
genes may involve the transcription factor HNF3b/Foxa2,
which was recently found to be a direct target of
miR124a in insulin-secreting cells (Baroukh et al., 2007).
Foxa2 controls the expression of several important b-cell
genes, including insulin (Kaestner, 2000; Wang et al.,
2002). Although it has not been reported that any of the
four genes is regulated by Foxa2, miR124a-mediated
transcriptional repression of this transcription factor may
possibly contribute to the effects on SNAP25, synapsin-
1A, Rab3A and Noc2 observed.
In this study, we found that miR124a overexpression
led to an increase in hormone secretion at low glucose
concentrations and a reduction in the cellular capacity to
respond to stimulatory conditions. It has been demon-
strated that overexpression of miR124a in insulin-secret-
ing cell lines increases the intracellular Ca2q concen-
tration at resting conditions and diminishes Ca2q eleva-
tion upon cell depolarization (Baroukh et al., 2007). These
changes in Ca2q signaling were attributed to reduced
activity of the ATP-sensitive Kq channel. In fact, expres-
sion of KIR6.2 and SUR1, the genes encoding the subu-
nits of the ATP-sensitive Kq channel, are controlled by
Foxa2 (Lantz et al., 2004). These changes in Ca2q sig-
naling are expected to raise basal insulin secretion and
decrease hormone release in the presence of secret-
agogues and could contribute to the effects of miR124a
observed in our study. An alternative explanation for the
effect of miR124a on basal secretion could be furnished
by the increase in SNAP25, since this SNARE protein
inactivates Kv2.1 voltage-dependent Kq channels (Mac-
Donald et al., 2002). A SNAP25-mediated blockade of
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voltage-dependent outward Kq currents could in princi-
ple prolong action potentials and enhance intracellular
Ca2q (MacDonald et al., 2001). However, this phenom-
enon is unlikely to explain the increase in basal secretion
in cells overexpressing miR124a. In fact, overexpression
of SNAP25 did not significantly affect basal secretion of
MIN6B1 cells. Under basal conditions, MIN6B1 cells over-
expressing SNAP25 released 7.5"0.8% of their hormone
content compared to the 6.8"0.8% obtained for cells
transfected with an empty vector.
Surprisingly, despite the changes in Ca2q homeostasis
observed and the fact that Foxa2 is essential for glucose-
induced insulin release (Wang et al., 2002), Baroukh et
al. (2007) did not detect significant changes in hormone
secretion in cells overexpressing miR124a. A possible
explanation for these contradictory findings is that vari-
ations in miR124a levels may differentially affect the
translational repression of miRNA targets. Since the indi-
vidual changes in gene expression elicited by miRNA can
have either beneficial or detrimental effects on secretion,
the final outcome may differ according to the level of
miR124a overexpression and the underlying cellular
context.
In this study we found that miR96 modulated the
expression of granuphilin and Noc2, two Rab3A- and
Rab27A-interacting proteins with important roles in insu-
lin secretion (Coppola et al., 2002; Cheviet et al., 2004;
Matsumoto et al., 2004; Gomi et al., 2005). At present,
there is almost no information available on this miRNA
and its function is unknown. miR96 is widely expressed,
but its level varies considerably in different tissues (Barad
et al., 2004). As is the case for miR9, miR96 increases
the expression of granuphilin, a protein with potent inhib-
itory action on insulin exocytosis (Coppola et al., 2002;
Gomi et al., 2005; Kato et al., 2006). The two miRNAs
affect granuphilin expression via two distinct mecha-
nisms. Thus, whereas miR9 functions by relieving the
inhibitory action exerted by OC2 (Plaisance et al., 2006),
the action of miR96 is independent of changes in the
level of this transcription factor. It has been demonstrated
that granuphilin expression is controlled by at least three
other transcription factors, SREBP-1 (Kato et al., 2006),
MafA (Kato et al., 2006) and ICER (Abderrahmani et al.,
2006). SREBP-1 and MafA positively modulate the activ-
ity of the granuphilin promoter, whereas ICER acts as a
transcriptional repressor. Future studies will have to
determine whether the effect of miR96 is mediated
through changes in the expression or activity of one of
these factors, or if it is due to perturbation of the function
of an additional transcriptional regulator yet to be iden-
tified. The negative action of miR96 on glucose-induced
insulin secretion is probably also linked to a decrease in
Noc2 levels. Noc2, in contrast to granuphilin, plays a
positive role in exocytosis. Indeed, a decrease in Noc2
content obtained by RNA interference or gene knockout
is associated with a defect in insulin secretion (Cheviet
et al., 2004; Gomi et al., 2005). The changes in Noc2
would add to the inhibitory effect provoked by higher
amounts of granuphilin, further reducing the cellular
capacity to respond appropriately to insulin
secretagogues.
In conclusion, this study has uncovered two additional
miRNAs that can both directly and indirectly control the
expression of key components of the machinery govern-
ing exocytosis in pancreatic b-cells. SNAP25, Rab3A,
Rab27A, granuphilin, Noc2 and synapsin-1A are essen-
tial modulators of the exocytotic process in many other
cells endowed with specialized secretory functions (Jahn,
2004; Fukuda, 2005). Thus, our findings can contribute
to understanding regulation of the exocytotic process not
only in insulin-secreting cells, but also in other neuro-
endocrine secretory systems.
Materials and methods
Cell culture and transient transfections
The insulin-secreting cell line MIN6 clone B1 (Lilla et al., 2003)
was cultured in 24- or 6-well dishes at a concentration of
1.3=105 cells/cm2 in DMEM-Glutamax medium supplemented
with 15% fetal calf serum, 50 IU/ml penicillin, 50 mg/ml strep-
tomycin and 70 mM b-mercaptoethanol. Transient transfections
were performed with Lipofectamine 2000 (Invitrogen, Carlsbad,
CA, USA) using a concentration of 1.33 ng/ml plasmids and/or
RNA duplexes. Co-transfection experiments were performed at
a plasmid/duplex mass ratio of 1:10.
RNA extraction and qRT-PCR assays
Total RNA extraction was performed using RNAqueous isolation
kits (Ambion, Austin, TX, USA). Conventional mRNA qRT-PCR
assays were carried out as previously described (Abderrahmani
et al., 2001) using GAPDH RNA as a control. Real-time PCR
assays were performed on a Bio-Rad MyiQ Single-Color Real-
Time PCR Detection System (Bio-Rad Laboratories, Hercules,
CA, USA). Primer sequences for mRNA PCR are available from
the authors upon request.
miRNA overexpression and plasmid construction
To increase the expression of miRNAs, cells were directly trans-
fected with RNA duplexes (Dharmacon, Lafayette, CO, USA, or
Eurogentec, Seraing, Belgium) corresponding to the mature
miRNA sequence (see miRNA Registry of the Sanger Institute;
http://microrna.sanger.ac.uk). An siRNA duplex directed against
GFP (sense, 59-GAC GUA AAC GGC CAC AAG UUC-39; anti-
sense, 59-ACU UGU GGC CGU UUA CGU CGC-39) with no
effect on pancreatic b-cell functions was used as a control. To
generate the RS-39UTR-Rab27a-luc and RS-39UTR-Noc2-luc
constructs, DNA oligonucleotides (Microsynth, Balgach, Swit-
zerland) containing the predicted miR124a recognition site of the
Rab27A 39UTR (NM_023635) or the Noc2 39UTR (NM_029548)
were inserted between the XhoI and EcoRI sites of the psi-
CHECK-1 plasmid (Promega, Madison, WI, USA). The multiple
cloning site of this plasmid is located in the 39UTR of the Renilla
luciferase gene between the stop codon and an artificial poly-
adenylation site. The oligonucleotide sequences were: RS-
39UTR-Rab27a-luc, sense, 59-TCG AGG CTG ATG GTC CTG
TCG CCT GCC TTA ACA CG-39; antisense, 59-AAT TCG TGT TAA
GGC AGG CGA CAG GAC CAT CAG CC-39; RS-39UTR-Noc2-
luc, sense, 59-TCG AGG ATT TTA AGT TTG CGC GTG TCT TGG
GTT G-39; and antisense, 59-AAT TCA ACC CAA GAC ACG CGC
AAA CTT AAA ATC C-39. To produce 39UTR-Rab27A-luc, a 270-
bp segment of the 39UTR of the mouse Rab27A gene containing
two potential miR124a recognition sites was amplified by PCR
from genomic DNA and inserted by the same way in the psi-
CHECK-1 vector. The sequences of the primers were: sense,
59-ACG CGC TCG AGC TTT GTA TGA TTT AGT CC-39; and anti-
sense, 59-AAT CTG AAT TCT CAA GAC CGT GC-39. The
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construction of 39UTR-OC2-luc was as previously described
(Plaisance et al., 2006).
Secretion assay
To assess secretory capacity, MIN6B1 cells (2.5=105) plated in
24-well dishes were transiently co-transfected with RNA
duplexes and with a construct encoding hGH. Three days later
the cells were washed and preincubated for 30 min in Krebs
buffer (127 mM NaCl, 4.7 mM KCl, 1 mM CaCl2, 1.2 mM KH2PO4,
1.2 mM MgSO4, 5 mM NaHCO3, 0.1% bovine serum albumin and
25 mM HEPES, pH 7.4) containing 2 mM glucose. The medium
was then discarded and the cells were incubated for 45 min
either in the same buffer (basal conditions) or in Krebs buffer
containing 20 mM glucose, 10 mM forskolin and 100 mM 3-iso-
butyl-1-methylxanthine (IBMX, stimulated condition). After col-
lecting the supernatant, cells were lysed in phospate-buffered
saline (PBS) containing 0.5% Triton X-100 to evaluate the hGH
content. The amount of hGH in samples was assessed using a
hGH ELISA kit (Roche Diagnostics, Rotkreuz, Switzerland).
Western blots and luciferase assays
For Western blot analysis, cells were washed once in PBS and
total extracts were obtained by lysing the cells using brief soni-
cation. Protein samples of 30 mg were loaded onto acrylamide
gels and transferred to polyvinylidene fluoride membranes. The
membranes were incubated overnight with primary antibodies
against syntaxin-1a and tubulin (Sigma, Buchs, Switzerland),
VAMP-2 and Rab3a (Synaptic System, Go¨ttingen, Germany) and
SNAP-25 (BD Biosciences, San Jose´, CA, USA). Antibodies
against Rab27a, Noc2 and synapsin-1a were kindly provided by
Dr. M. Seabra (Imperial College, London, UK), Dr. B. Burgoyne
(University of Liverpool, UK) and Dr. B. Riederer (University of
Lausanne, Switzerland), respectively. Immunoreactive bands
were visualized using either a chemiluminescent substrate
(Amersham Biosciences, Piscataway, NJ, USA) after incubation
with a secondary horseradish peroxidase-coupled antibody or
an Odyssey infrared imaging system (Li-cor Biosciences, Bad
Homburg, Germany) that reveals dye-conjugated secondary
antibodies (Rockland, Gilbertsville, PA, USA). Luciferase activity
was measured 2 days after transfection with a dual luciferase
reporter assay system (Promega). Renilla luciferase activity
produced from psiCHECK-1, RS-3’UTR-Rab27a-luc, 3’UTR-
Rab27a-luc, RS-3’UTR-Noc2-luc and 3’UTR-OC2-luc plasmids
was normalized to the activity obtained from a co-transfected
SV40 PGL3 promoter plasmid (Promega).
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